These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15929792

  • 1. Bacterial activity in cystic fibrosis lung infections.
    Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Kehagia V, Jones GR, Bruce KD.
    Respir Res; 2005 Jun 01; 6(1):49. PubMed ID: 15929792
    [Abstract] [Full Text] [Related]

  • 2. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling.
    Rogers GB, Hart CA, Mason JR, Hughes M, Walshaw MJ, Bruce KD.
    J Clin Microbiol; 2003 Aug 01; 41(8):3548-58. PubMed ID: 12904354
    [Abstract] [Full Text] [Related]

  • 3. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.
    Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Kehagia V, Connett GJ, Bruce KD.
    J Clin Microbiol; 2006 Jul 01; 44(7):2601-4. PubMed ID: 16825392
    [Abstract] [Full Text] [Related]

  • 4. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
    Spasenovski T, Carroll MP, Payne MS, Bruce KD.
    Diagn Microbiol Infect Dis; 2009 Mar 01; 63(3):261-7. PubMed ID: 19216939
    [Abstract] [Full Text] [Related]

  • 5. characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.
    Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD.
    J Clin Microbiol; 2004 Nov 01; 42(11):5176-83. PubMed ID: 15528712
    [Abstract] [Full Text] [Related]

  • 6. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients.
    Kolak M, Karpati F, Monstein HJ, Jonasson J.
    Int J Med Microbiol; 2003 Aug 01; 293(4):309-17. PubMed ID: 14503795
    [Abstract] [Full Text] [Related]

  • 7. Methods to classify bacterial pathogens in cystic fibrosis.
    Bjarnsholt T, Nielsen XC, Johansen U, Nørgaard L, Høiby N.
    Methods Mol Biol; 2011 Aug 01; 742():143-71. PubMed ID: 21547731
    [Abstract] [Full Text] [Related]

  • 8. Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches.
    Rogers GB, Daniels TW, Tuck A, Carroll MP, Connett GJ, David GJ, Bruce KD.
    BMC Pulm Med; 2009 Apr 15; 9():14. PubMed ID: 19368727
    [Abstract] [Full Text] [Related]

  • 9. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.
    Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS.
    Am J Respir Crit Care Med; 2008 May 01; 177(9):995-1001. PubMed ID: 18263800
    [Abstract] [Full Text] [Related]

  • 10. RISA-HPLC analysis of lung bacterial colonizers of cystic fibrosis children.
    Nazaret S, Assade F, Brothier E, Freydière AM, Bellon G, Cournoyer B.
    J Microbiol Methods; 2009 Jan 01; 76(1):58-69. PubMed ID: 18929602
    [Abstract] [Full Text] [Related]

  • 11. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A, Renders NH, Smith S, Overbeek SE, Verbrugh HA.
    FEMS Immunol Med Microbiol; 2000 Jan 01; 27(1):51-7. PubMed ID: 10617790
    [Abstract] [Full Text] [Related]

  • 12. Characterization of bacterial community diversity in chronic rhinosinusitis infections using novel culture-independent techniques.
    Stressmann FA, Rogers GB, Chan SW, Howarth PH, Harries PG, Bruce KD, Salib RJ.
    Am J Rhinol Allergy; 2011 Jan 01; 25(4):e133-40. PubMed ID: 21819748
    [Abstract] [Full Text] [Related]

  • 13. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A, Mahenthiralingam E, Moore JE, Dunbar KE, Webb AK, Dodd ME, Martin SL, Millar BC, Scott CJ, Crowe M, Elborn JS.
    J Clin Microbiol; 2001 Dec 01; 39(12):4247-55. PubMed ID: 11724828
    [Abstract] [Full Text] [Related]

  • 14. Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.
    Flight WG, Smith A, Paisey C, Marchesi JR, Bull MJ, Norville PJ, Mutton KJ, Webb AK, Bright-Thomas RJ, Jones AM, Mahenthiralingam E.
    J Clin Microbiol; 2015 Jul 01; 53(7):2022-9. PubMed ID: 25878338
    [Abstract] [Full Text] [Related]

  • 15. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.
    Stressmann FA, Rogers GB, van der Gast CJ, Marsh P, Vermeer LS, Carroll MP, Hoffman L, Daniels TW, Patel N, Forbes B, Bruce KD.
    Thorax; 2012 Oct 01; 67(10):867-73. PubMed ID: 22707521
    [Abstract] [Full Text] [Related]

  • 16. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
    Karpati F, Jonasson J.
    Mol Cell Probes; 1996 Dec 01; 10(6):397-403. PubMed ID: 9025076
    [Abstract] [Full Text] [Related]

  • 17. Application of reverse transcriptase PCR-based T-RFLP to perform semi-quantitative analysis of metabolically active bacteria in dairy fermentations.
    Sánchez JI, Rossetti L, Martínez B, Rodríguez A, Giraffa G.
    J Microbiol Methods; 2006 May 01; 65(2):268-77. PubMed ID: 16181692
    [Abstract] [Full Text] [Related]

  • 18. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
    Sanderson K, Wescombe L, Kirov SM, Champion A, Reid DW.
    Eur Respir J; 2008 Aug 01; 32(2):329-33. PubMed ID: 18480103
    [Abstract] [Full Text] [Related]

  • 19. Development of a novel PCR assay for the identification of the black yeast, Exophiala (Wangiella) dermatitidis from adult patients with cystic fibrosis (CF).
    Nagano Y, Elborn JS, Millar BC, Goldsmith CE, Rendall J, Moore JE.
    J Cyst Fibros; 2008 Nov 01; 7(6):576-80. PubMed ID: 18571996
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.
    Stressmann FA, Rogers GB, Klem ER, Lilley AK, Donaldson SH, Daniels TW, Carroll MP, Patel N, Forbes B, Boucher RC, Wolfgang MC, Bruce KD.
    J Clin Microbiol; 2011 Jan 01; 49(1):281-91. PubMed ID: 21068277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.